Skip to content

Healthcare Intelligence Asia

  • Sample Page
  • Privacy Policy
  • Healthcare Intelligence Asia
  • About Healthcare Intelligence Asia
  • Advertise With Healthcare Intelligence Asia
  • Terms of Use
  • Subscribe
  • Archive

Vela Diagnostics USA

ABL Texcell Diagnostics abandons Vela’s Singapore and US acquisition

October 29, 2026October 29, 2026
Illustration of a document marked Cancelled against an empty background, representing the abandoned acquisition.

The proposed purchase followed an exclusive distribution partnership covering Europe, the Middle East and Africa. Vela’s Singapore customers have a separate interest in supply and support commitments after the planned purchase was abandoned.

Categories Investment Tags ABL Texcell Diagnostics, Vela Diagnostics, Vela Diagnostics USA, Vela Operations Singapore Leave a comment

Recent Posts

  • Vietnam hospitals redirect cancer patients as PET/CT drugs run short
  • IHH to acquire Afiniti Wellness for Johor outpatient expansion
  • Genie Health raises $3 million for Singapore health AI
  • MNEX plans mixed-use components plant in the Philippines
  • ABL Texcell Diagnostics abandons Vela’s Singapore and US acquisition

Recent Comments

  1. A WordPress Commenter on Hello world!
© 2026 Healthcare Intelligence Asia • Built with GeneratePress